These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37818094)

  • 21. Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity.
    Morrow RM; Picard M; Derbeneva O; Leipzig J; McManus MJ; Gouspillou G; Barbat-Artigas S; Dos Santos C; Hepple RT; Murdock DG; Wallace DC
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2705-2710. PubMed ID: 28223503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions.
    Forsström S; Jackson CB; Carroll CJ; Kuronen M; Pirinen E; Pradhan S; Marmyleva A; Auranen M; Kleine IM; Khan NA; Roivainen A; Marjamäki P; Liljenbäck H; Wang L; Battersby BJ; Richter U; Velagapudi V; Nikkanen J; Euro L; Suomalainen A
    Cell Metab; 2019 Dec; 30(6):1040-1054.e7. PubMed ID: 31523008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress.
    Ost M; Igual Gil C; Coleman V; Keipert S; Efstathiou S; Vidic V; Weyers M; Klaus S
    EMBO Rep; 2020 Mar; 21(3):e48804. PubMed ID: 32026535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
    Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress.
    Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS
    Diabetologia; 2015 Apr; 58(4):809-18. PubMed ID: 25537833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine.
    Kim KH; Jeong YT; Oh H; Kim SH; Cho JM; Kim YN; Kim SS; Kim DH; Hur KY; Kim HK; Ko T; Han J; Kim HL; Kim J; Back SH; Komatsu M; Chen H; Chan DC; Konishi M; Itoh N; Choi CS; Lee MS
    Nat Med; 2013 Jan; 19(1):83-92. PubMed ID: 23202295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
    Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
    Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
    Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
    Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF21 regulates insulin sensitivity following long-term chronic stress.
    Jelenik T; Dille M; Müller-Lühlhoff S; Kabra DG; Zhou Z; Binsch C; Hartwig S; Lehr S; Chadt A; Peters EMJ; Kruse J; Roden M; Al-Hasani H; Castañeda TR
    Mol Metab; 2018 Oct; 16():126-138. PubMed ID: 29980484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets.
    Macia L; Tsai VW; Nguyen AD; Johnen H; Kuffner T; Shi YC; Lin S; Herzog H; Brown DA; Breit SN; Sainsbury A
    PLoS One; 2012; 7(4):e34868. PubMed ID: 22514681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GDF15 deficiency promotes high fat diet-induced obesity in mice.
    Tran T; Yang J; Gardner J; Xiong Y
    PLoS One; 2018; 13(8):e0201584. PubMed ID: 30070999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
    Salminen A; Kaarniranta K; Kauppinen A
    Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.